Navigation Links
AGA Medical Corporation Launches Fourth Web-Based Stroke Education and Awareness Video Featuring Professional Football Player Tedy Bruschi
Date:4/28/2009

MINNEAPOLIS, April 28 /PRNewswire/ -- AGA Medical Corporation today launched the fourth in a series of web-based stroke education and awareness videos featuring Tedy Bruschi, a professional football player who suffered a stroke in February 2005, subsequently recovered and returned to his career. The new video features Tedy describing his return to professional football after suffering a stroke. The video is the crescendo of Tedy's story following the previous three videos in the series, released in January through March. It will be followed by one last video posted on the AGA Medical website that describes Tedy's firsthand experience as a stroke victim, survivor and prevention champion.

"I hope that by sharing my experiences through the video series people will come to understand the important risk factors for stroke, learn to quickly identify the warning signs and be better prepared should they themselves or a loved one, colleague or neighbor experience a stroke," said Tedy Bruschi. "I know firsthand the emotional and physical challenges that experiencing a stroke can lead to. My hope is that the content of the program developed with AGA Medical may help other stroke survivors achieve a positive recovery. That is why this effort is so important to me."

AGA Medical announced its partnership with Tedy Bruschi in December 2008 with the release of a video in which Tedy describes the warning signs of stroke. In January, the national stroke awareness program's next initiative - a series of five inspirational videos of Tedy discussing his personal experience with stroke and educating others about warning signs - kicked off with the release of a video describing Tedy's life prior to his stroke. Each month though May, AGA Medical Corporation and Tedy will team up to release a new video. Visitors to the www.amplatzer.com/strokeawareness website will be able to view all videos released to date. AGA Medical Corporation will launch additional initiatives throughout 2009 to build upon this comprehensive stroke education, awareness and prevention campaign.

"We believe that sharing Tedy's story of his return to professional football is a way to inspire those recovering from stroke," said John Barr, chief executive officer of AGA Medical. "As we continue our research for potential therapies in stroke prevention, Tedy's return to professional football sends a message of remarkable hope and relentless recovery to stroke survivors like Tedy."

Stroke, defined as a sudden injury to the brain caused by a blood vessel bursting or becoming blocked, is the nation's number 3 cause of death behind heart disease and cancer. The American Heart Association reports that each year, about 700,000 Americans suffer from a stroke. One-third of stroke victims are under 65, and even children can suffer a stroke.

About Tedy Bruschi

Coming off the success of winning his 3rd league championship and playing in the annual league all-star game in February of 2005, Tedy unexpectedly experienced a stroke. On the advice of his physician, a device from AGA Medical was prescribed and implanted as part of Tedy's treatment. After several months of extensive rehabilitation and recovery, Tedy was medically cleared to resume playing football less than a year later. Today, in addition to his continued success on the field, Tedy dedicates a considerable part of his time off the field toward raising stroke awareness and funds for stroke research.

To learn more about Tedy and the warning signs of stroke, visit www.amplatzer.com/strokeawareness.

Clinical Trial Underway

AGA Medical is currently conducting a multicenter, randomized clinical study, known as the RESPECT trial, to investigate whether closure of a congenital heart defect using an AGA Medical device is superior to current standard of care treatment in the prevention of a particular type of stroke. For more information on the clinical trial and the warning signs of stroke, visit www.amplatzer.com.

About AGA Medical Corporation

AGA Medical Corporation, based in Plymouth, Minnesota, is a leader in developing interventional devices for the minimally invasive treatment of cardiovascular defects and peripheral vascular disease. Founded in 1995 by Dr. Kurt Amplatz, a former professor and researcher at the University of Minnesota Department of Radiology, AGA Medical develops and commercializes devices for a range of structural heart repair and circulatory conditions. Several of these devices have been major innovations in the treatment of the most common congenital "holes in the heart", such as atrial septal defects and patent foramen ovales.

More than 700 articles have been published in medical literature that support the benefits of AGA Medical devices, including improved patient outcomes, reduced length of stay, and accelerated recovery times for the patient. AGA Medical devices have received regulatory approval and are marketed in 101 countries. For more information, visit www.amplatzer.com.


'/>"/>
SOURCE AGA Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FEMA Adds Masimo Rad-57(R) Pulse CO-Oximeter(TM) to Required Medical Equipment List
2. WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System
3. Meaningful Connections Offers Guidance, Case Examples for use of Electronic Health IT to Support Patient Centered Medical Home
4. Hollywood Presbyterian Medical Center: Taking the Message of Trust to the Streets of LA
5. Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award
6. ATS Medical Appoints New Vice President of Marketing
7. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
8. MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development
9. New doctors, teaching physicians disagree about essential medical procedures to learn
10. Medical Nurse Training, Inc. Announces New Techniques to Achieve Tremendous Savings of Lives and Medical Costs of Over $200 Billion Annually
11. As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology: